The first official results regarding the tests on the disinfectants supplied by Hexi Pharma across Romanian hospitals show that the substances have been indeed diluted up to ten times. The government representatives announced in a press conference on Wednesday that all analyzed samples proved to be inaccurate and that the Executive considers suing the Hexi Pharma company.
The samples tested at ICECHIM (The National Institute for Research&Development in Chemistry and Petrochemistry) on the Hexi Pharma products show big concentration differences between the declared value and the one tested in the lab.
Thus, the declared value of the ammonium chloride was 15% and the measured one was 5.18%. An iodine product had a declared value of 10% and the real one was 7.41%, said Victor Strâmbu, secretary of state within the Health Ministry. The glutaraldehyde substance was 12% on the label, but the real value was only 1,23%.
He announced that all these products would be withdrawn from hospitals, and the company would receive a fine of RON 40,000.
The secretary of state also informed that the state health inspection on Hexi Pharma products had been concluded and the report would be available in two days, adding that meanwhile the inaccurate products would be withdrawn.
In his turn, the Government’s spokesperson Dan Suciu said that the Executive doesn’t rule out suing Hexi Pharma.
Suciu said that cross checks would follow across hospitals countrywide in the upcoming period, recommending the hospitals to stop using Hexi Pharma products and to buy other biocide substances.
The law stipulates that hospitals can purchase direct products of maximum EUR 15,000.
At the same time, the Government tightened the penalties for false statements on biocide substances, meaning that a company lying about the disinfectant’s content and concentration could receive a fine from RON 35,000 to RON 50,000.
Serious accusations are brought against the owners of Hexi Pharma, the company which allegedly has got rich in recent years from contracts with the Romanian state. According to ‘Gazeta Sporturilor’ journalists, the company bought active substances for disinfectants through offshore companies in Cyprus, then the prices were hiked by 7 times.
The recipe, finally contracted with the hospitals in Romania, was based on a disinfectant diluted 10 times and by 7 times more expensive. More specifically, the off-shore controlled by the owner of Hexi Pharma bought the active substance for disinfectants for EUR 11/kg and resold it through Hexi Pharma for EUR 73/kg.
The difference remained in the accounts in Cyprus.